Monoclonal antibody for detecting human alpha-fetoprotein, kit and application

A monoclonal antibody and alpha-fetoprotein technology, applied in the biological field, can solve the problems of linear range and sensitivity that need to be further improved, lack of clinical application value, inability to develop and produce kits, and achieve good detection results

Active Publication Date: 2017-08-08
广东谷盈生物科技产业研究院有限公司
View PDF4 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although anti-hAFP monoclonal antibodies have been successfully prepared at home and abroad, most of them do not have clinical application value and cannot be used for kit development and production
Among the hAFP detection ELISA kit product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody for detecting human alpha-fetoprotein, kit and application
  • Monoclonal antibody for detecting human alpha-fetoprotein, kit and application
  • Monoclonal antibody for detecting human alpha-fetoprotein, kit and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] The preparation of embodiment 1 monoclonal antibody

[0050] Antigen human alpha-fetoprotein (Human Myoglobin) was purchased from Guilin Inmate Biotechnology Co., Ltd., isolated and purified from human umbilical cord blood, and its concentration was 7.6mg / ml. composed of amino acid residues. hAFP is a multifunctional transporter that is highly expressed in the fetus and silenced after birth. Serum hAFP concentration is a direct or indirect evaluation index of many diseases, especially common in prenatal diagnosis and liver cancer diagnosis and condition monitoring.

[0051] The preparation method of anti-human alpha-fetoprotein mouse monoclonal antibody is as follows:

[0052] (1) Animal immunity

[0053] 1) Initial immunization: 30 μg of antigen plus an equal volume of complete Freund's adjuvant is fully emulsified and injected subcutaneously into mice at multiple points;

[0054] 2) Secondary immunization: 2 weeks later, the same amount of antigen as the first imm...

Embodiment 2

[0095] The specificity analysis of embodiment 2 monoclonal antibody

[0096] The four important monoclonal antibodies Ab 1-A b 4 screened above all have very high affinity to the immunogen hAFP. In order to further identify their specificity and verify whether they can specifically bind to naturally occurring hAFP, they were tested in cells The following two experiments were designed at the level and organizational level.

[0097] 1) Immunofluorescence staining of HepG2 human liver cancer cells

[0098]It is known that human liver cancer cells HepG2 can synthesize a large amount of hAFP in the cells, and the four monoclonal antibodies Ab1-Ab 4 were used for cell fluorescence staining experiments.

[0099] Experimental method: ① One day before the experiment, take HepG2 cells in good condition to make a cell suspension, and count the cells at a cell concentration of 5×10 5 Place the amount of cells / well into the wells of a six-well plate with coverslips placed; ②Cultivate in ...

Embodiment 3

[0110] Example 3 Sequence and structure analysis of monoclonal antibodies Ab1-Ab4

[0111] Further sequence and structural analysis of the obtained monoclonal antibodies Ab 1, Ab 3, and Ab 4 revealed that the variable regions of Ab 1, Ab 3, and Ab 4 all include a heavy chain variable region and a light chain variable region.

[0112] (1) From the perspective of gene sequence:

[0113] The gene sequence of the heavy chain variable region of the monoclonal antibody Ab1 is shown in SEQ ID NO.1, and the gene sequence of the light chain variable region is shown in SEQ ID NO.2;

[0114] The gene sequence of the heavy chain variable region of the monoclonal antibody Ab3 is shown in SEQ ID NO.3, and the gene sequence of the light chain variable region is shown in SEQ ID NO.4;

[0115] The gene sequence of the heavy chain variable region of the monoclonal antibody Ab4 is shown in SEQ ID NO.5, and the gene sequence of the light chain variable region is shown in SEQ ID NO.6.

[0116] (...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The invention discloses a monoclonal antibody for detecting human alpha-fetoprotein, a kit and application. Three monoclonal antibodies including monoclonal antibodies Ab1, Ab3 and Ab4 can be used for specifically identifying human-derived natural hAFP (human Alpha-fetoprotein) in human hepatocellular carcinoma cells and hepatocellular carcinoma tissues and have very good specificity. The invention discloses a mouse-derived monoclonal antibody capable of being specifically combined with the human alpha-fetoprotein; the antibody can be combined with different epitopes of the human alpha-fetoprotein to form a double-antibody sandwich mode, so that quantitative detection of the alpha-fetoprotein in human blood serum is realized; the monoclonal antibody has a certain effect on prenatal diagnosis and early diagnosis of hepatocellular carcinoma and has very good popularization and application value.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a monoclonal antibody for detecting alpha-fetoprotein, a kit and application thereof. Background technique [0002] Human alpha fetoprotein (hAFP) is an embryonic glycoprotein synthesized by fetal liver cells and yolk sac, its function is similar to that of human serum albumin (HSA), and it can be regarded as fetal HSA replacement during developmental period. Under normal circumstances, hAFP only exists in fetal serum, and the concentration of hAFP can drop back to the normal level (<5ng / ml) after one year of fetal birth, and the concentration in normal human serum is generally not higher than 20ng / ml. When primary liver cancer occurs in the body, the liver cancer cells can secrete a large amount of hAFP in the peripheral blood, causing an abnormal increase in blood hAFP concentration. [0003] hAFP is one of the earliest tumor markers discovered. It has long been us...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/18G01N33/577G01N33/574
CPCC07K16/18C07K2317/33C07K2317/565C07K2317/92G01N33/57438G01N33/57488G01N33/577G01N2333/471
Inventor 向军俭黄建芳孙一帆杨少彬
Owner 广东谷盈生物科技产业研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products